Skip to main content
Livermore
Livermore
ZHEN

Heron Therapeutics, Inc.

HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000818033

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Heron Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of HRTX: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders1412151+12
Shares118.4M328.2K112.5M−5.60M (−4.7%)
Value$121.9M$338.1K$191.2M+$69.6M (+57.2%)

2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Heron Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to HRTX in Q4 2023
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP339,448$577.0K0.05%
Zacks Investment Management311,429$529.4K0.01%
HRT Financial LP199,908$339.0K0.00%
Panagora Asset Management Inc139,113$236.5K0.00%
Acadian Asset Management LLC134,877$229.0K0.00%
XTX Topco Ltd104,274$177.3K0.04%
Propel Bio Management, LLC104,195$177.1K0.15%
Motiv8 Investments LLC77,731$132.1K0.12%
Cubist Systematic Strategies, LLC53,622$91.2K0.00%
Integrated Wealth Concepts LLC32,000$54.4K0.00%
State Board of Administration of Florida Retirement System26,894$45.7K0.00%
ACT Advisors, LLC.22,145$37.6K0.02%
Simplex Trading, LLC20,598$35.0K0.00%
Bayesian Capital Management, LP20,300$34.5K0.00%
Point72 Middle East FZE18,500$31.4K0.00%
DLK Investment Management, LLC17,890$30.4K0.01%
Wolverine Trading, LLC16,721$28.4K0.00%
JustInvest LLC13,138$22.3K0.00%
Glenmede Trust Co NA11,873$20.2K0.00%
Capital Investment Counsel, Inc11,500$19.6K0.00%
National Asset Management, Inc.11,490$19.5K0.00%
XML Financial, LLC10,000$17.0K0.00%
Gleason Group, Inc.6,670$11.3K0.00%
Advisory Services Network, LLC1,479$2.51K0.00%
Raleigh Capital Management Inc.1,453$2.47K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC1,307$2.22K0.00%
ORG Partners LLC400$6800.00%
Allworth Financial LP301$5120.00%
Fortitude Family Office, LLC281$4780.00%
Game Plan Financial Advisors, LLC100$1700.00%

Sold out (18)

Institutions that held Heron Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of HRTX in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Baker Bros. Advisors LP8,131,678$8.38M
Great Point Partners LLC4,737,368$4.88M
Deep Track Capital, LP2,086,704$2.15M
Simplify Asset Management Inc.431,590$444.5K
Ameriprise Financial Inc277,538$285.9K
Mutual of America Capital Management LLC227,287$234.1K
Graham Capital Management, L.P.146,872$151.3K
Susquehanna Fundamental Investments, LLC116,363$119.9K
Allspring Global Investments Holdings, LLC41,034$42.3K
Biltmore Family Office, LLC16,425$16.9K
Quantbot Technologies LP10,992$11.3K
Qube Research & Technologies Ltd6,021$6.20K
WR Wealth Planners, LLC3,800$3.91K
GWM Advisors LLC2,800$2.88K
IFP Advisors, Inc271$279
Russell Investments Group, Ltd.200$206
Beaird Harris Wealth Management, LLC148$153
CWM, LLC450$0

Not filed for Q4 2023 yet (2)

Institutions that held Heron Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HRTX in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Jacob Asset Management of New York LLC327,450$337.3K
Tang Kevin C760$783